BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18922878)

  • 1. Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells.
    Shabman RS; Rogers KM; Heise MT
    J Virol; 2008 Dec; 82(24):12374-83. PubMed ID: 18922878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses.
    Shabman RS; Morrison TE; Moore C; White L; Suthar MS; Hueston L; Rulli N; Lidbury B; Ting JP; Mahalingam S; Heise MT
    J Virol; 2007 Jan; 81(1):237-47. PubMed ID: 17079324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of envelope N-linked glycosylation in Ross River virus virulence and transmission.
    Nelson MA; Herrero LJ; Jeffery JAL; Hoehn M; Rudd PA; Supramaniam A; Kay BH; Ryan PA; Mahalingam S
    J Gen Virol; 2016 May; 97(5):1094-1106. PubMed ID: 26813162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmacytoid Dendritic Cells Mediate Control of Ross River Virus Infection via a Type I Interferon-Dependent, MAVS-Independent Mechanism.
    Haist KC; Carpentier KS; Davenport BJ; Morrison TE
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus.
    Tharmarajah K; Everest-Dass A; Vider J; Liu X; Freitas JR; Mostafavi H; Bettadapura J; von Itzstein M; West NP; Taylor A; Mahalingam S; Zaid A
    J Virol; 2022 Sep; 96(17):e0099922. PubMed ID: 36000846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.
    Liu X; Mutso M; Cherkashchenko L; Zusinaite E; Herrero LJ; Doggett SL; Haniotis J; Merits A; Herring BL; Taylor A; Mahalingam S
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31996431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Virulence of Ross River Virus Harboring a Mutation in the First Cleavage Site of Nonstructural Polyprotein Is Caused by a Novel Mechanism Leading to Increased Production of Interferon-Inducing RNAs.
    Liu X; Mutso M; Utt A; Lepland A; Herrero LJ; Taylor A; Bettadapura J; Rudd PA; Merits A; Mahalingam S
    mBio; 2018 Aug; 9(4):. PubMed ID: 30131356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF)-Dependent Antiviral Responses Protect Mice against Ross River Virus Disease.
    Liu X; Taylor A; Poo YS; Ng WH; Herrero LJ; Tang PCH; Zaid A; Mahalingam S
    mBio; 2022 Feb; 13(1):e0336321. PubMed ID: 35089088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA; Lozach PY; Amara A; Gamarnik AV
    J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.
    Hidmark AS; McInerney GM; Nordström EK; Douagi I; Werner KM; Liljeström P; Karlsson Hedestam GB
    J Virol; 2005 Aug; 79(16):10376-85. PubMed ID: 16051830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ross River virus mutant with a deletion in the E2 gene: properties of the virion, virus-specific macromolecule synthesis, and attenuation of virulence for mice.
    Vrati S; Faragher SG; Weir RC; Dalgarno L
    Virology; 1986 Jun; 151(2):222-32. PubMed ID: 3010551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lentiviral vector pseudotype suitable for vaccine development.
    Lopes L; Dewannieux M; Takeuchi Y; Collins MK
    J Gene Med; 2011 Mar; 13(3):181-7. PubMed ID: 21394858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
    Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
    Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts.
    Jupille HJ; Medina-Rivera M; Hawman DW; Oko L; Morrison TE
    J Virol; 2013 May; 87(10):5970-84. PubMed ID: 23514884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus.
    Taylor A; Melton JV; Herrero LJ; Thaa B; Karo-Astover L; Gage PW; Nelson MA; Sheng KC; Lidbury BA; Ewart GD; McInerney GM; Merits A; Mahalingam S
    J Virol; 2016 Apr; 90(8):4150-4159. PubMed ID: 26865723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ross River virus envelope glycans contribute to disease through activation of the host complement system.
    Gunn BM; Jones JE; Shabman RS; Whitmore AC; Sarkar S; Blevins LK; Morrison TE; Heise MT
    Virology; 2018 Feb; 515():250-260. PubMed ID: 29324290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells.
    Strang BL; Takeuchi Y; Relander T; Richter J; Bailey R; Sanders DA; Collins MK; Ikeda Y
    J Virol; 2005 Feb; 79(3):1765-71. PubMed ID: 15650201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-linked glycans on dengue viruses grown in mammalian and insect cells.
    Hacker K; White L; de Silva AM
    J Gen Virol; 2009 Sep; 90(Pt 9):2097-106. PubMed ID: 19494052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection.
    Stoermer Burrack KA; Hawman DW; Jupille HJ; Oko L; Minor M; Shives KD; Gunn BM; Long KM; Morrison TE
    J Virol; 2014 Apr; 88(7):3719-32. PubMed ID: 24429363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid differentiation of monocytes into type I IFN-producing myeloid dendritic cells as an antiviral strategy against influenza virus infection.
    Cao W; Taylor AK; Biber RE; Davis WG; Kim JH; Reber AJ; Chirkova T; De La Cruz JA; Pandey A; Ranjan P; Katz JM; Gangappa S; Sambhara S
    J Immunol; 2012 Sep; 189(5):2257-65. PubMed ID: 22855715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.